Brian M. Strem
President, CEO & DirectorDr. Brian M. Strem, Ph.D., is Co-Founder and Director at Okogen, Inc. He served as Principal Financial and Accounting Officer of Kiora Pharmaceuticals, Inc. since June 16, 2022. He serves as President, Director and Chief Executive Officer at Kiora Pharmaceuticals, Inc. (formerly known as EyeGate Pharmaceuticals, Inc.) since July 23, 2021 and served as its Principal Financial Officer and Principal Accounting Officer from March 18, 2022 until April 21, 2022. He is a co-Founder of Yellowbrick Bio LLC d/b/a Bayon Therapeutics (“Bayon”), an ophthalmological pharmaceutical company based on a novel, light responsive small molecule platform. Kiora acquired Bayon Therapeutics in October 2021. Dr. Strem was Managing Director of Bayon from March 2020 until the acquisition. Dr. Strem is a co-Founder of Okogen, Inc., a development stage ophthalmic company focused on a novel therapeutic for the treatment of viral infections of the eye, and served as its CEO from May 2015 through July 2021. Prior to founding Okogen, Dr. Strem worked at Sound Pharmaceuticals, Inc., Allergan, Inc. and Shire, Plc, where he was responsible for business development and corporate strategy in ophthalmology, otology and regenerative medicine. Dr. Strem began his career at Cytori Therapeutics with elevating roles within the commercial and research and development departments. Dr. Strem received a BS in bioengineering from Cornell University and a Ph.D. in biomedical engineering from the University of California, Los Angeles.
Positions
- Company NameKiora Pharmaceuticals, Inc.Stock CodeKPRXPositionPresident, CEO & DirectorColleagues
- PTPraveen TyleIndependent Chairman of the Board
- MTMelissa ToscaChief Financial Officer
- SSStefan SperlExecutive Vice President of CMC & Operations
- KJKeith J. LaneExecutive VP and Head of Clinical Development & Regulatory Affairs
- DADavid A. HollanderIndependent Director
- EPErin ParsonsNon-Employee Independent Director
- LWLisa Walters-HoffertIndependent Director
